CDC Stock Overview
Cityland Development Corporation, together with its subsidiaries, develops, leases, and sells real estate properties in the Philippines.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Cityland Development Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₱0.70 |
52 Week High | ₱0.80 |
52 Week Low | ₱0.65 |
Beta | 0.029 |
1 Month Change | -2.78% |
3 Month Change | -1.41% |
1 Year Change | -1.71% |
3 Year Change | -23.13% |
5 Year Change | -9.72% |
Change since IPO | -65.57% |
Recent News & Updates
Recent updates
Shareholder Returns
CDC | PH Real Estate | PH Market | |
---|---|---|---|
7D | -1.4% | -8.2% | -3.6% |
1Y | -1.7% | -7.7% | -1.2% |
Return vs Industry: CDC exceeded the PH Real Estate industry which returned -7.7% over the past year.
Return vs Market: CDC matched the PH Market which returned -1.2% over the past year.
Price Volatility
CDC volatility | |
---|---|
CDC Average Weekly Movement | 3.9% |
Real Estate Industry Average Movement | 6.3% |
Market Average Movement | 4.9% |
10% most volatile stocks in PH Market | 11.7% |
10% least volatile stocks in PH Market | 2.6% |
Stable Share Price: CDC has not had significant price volatility in the past 3 months.
Volatility Over Time: CDC's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1978 | 183 | Josef Gohoc | www.cityland.info |
Cityland Development Corporation, together with its subsidiaries, develops, leases, and sells real estate properties in the Philippines. The company develops medium to high-rise offices, and commercial and residential condominiums, as well as parking slots; and residential subdivisions and farmlots. It also establishes, organizes, develops, maintains, conducts, operates, markets, and sells pension plans, as well as invests in trust funds.
Cityland Development Corporation Fundamentals Summary
CDC fundamental statistics | |
---|---|
Market cap | ₱3.48b |
Earnings (TTM) | ₱882.56m |
Revenue (TTM) | ₱3.04b |
3.9x
P/E Ratio1.1x
P/S RatioIs CDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CDC income statement (TTM) | |
---|---|
Revenue | ₱3.04b |
Cost of Revenue | ₱1.18b |
Gross Profit | ₱1.86b |
Other Expenses | ₱974.51m |
Earnings | ₱882.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.18 |
Gross Margin | 61.15% |
Net Profit Margin | 29.06% |
Debt/Equity Ratio | 10.7% |
How did CDC perform over the long term?
See historical performance and comparison